These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38096801)
21. Growing teratoma syndrome: an unusual evolution of treated ovarian immature teratoma - a case report. Gomez-Portilla A; Bustamante R; Lopez de Heredia E; Lete LI; Cuadra M; Dominguez S Eur J Gynaecol Oncol; 2016; 37(5):729-731. PubMed ID: 29787021 [TBL] [Abstract][Full Text] [Related]
22. Gliomatosis peritonei: a series of eight cases and review of the literature. Wang D; Jia CW; Feng RE; Shi HH; Sun J J Ovarian Res; 2016 Jul; 9(1):45. PubMed ID: 27473411 [TBL] [Abstract][Full Text] [Related]
23. Clinical Management and Outcome in Extreme Retroperitoneal Growing Teratoma Syndrome of Testicular Origin - Clinical Management and Effect of the Treatment. Huľová S; Aziri R; Chovanec M; Mardiak J; Mego M; Pinďák D Klin Onkol; 2019; 32(2):129-132. PubMed ID: 30995853 [TBL] [Abstract][Full Text] [Related]
24. The impact of ultra-radical surgery in the management of patients with stage IIIC and IV epithelial ovarian, fallopian tube, and peritoneal cancer. Turnbull HL; Akrivos N; Wemyss-Holden S; Maiya B; Duncan TJ; Nieto JJ; Burbos N Arch Gynecol Obstet; 2017 Mar; 295(3):681-687. PubMed ID: 27995370 [TBL] [Abstract][Full Text] [Related]
25. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer. Yao SE; Tripcony L; Sanday K; Robertson J; Perrin L; Chetty N; Land R; Garrett A; Obermair A; Nascimento M; Tang A; Jagasia N; Singh P; Nicklin J Int J Gynecol Cancer; 2020 Dec; 30(12):1935-1942. PubMed ID: 33122245 [TBL] [Abstract][Full Text] [Related]
26. [Clinical features and prognostic factors of malignant ovarian teratoma]. Jin FM; Zhu GZ; Feng YJ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):427-30. PubMed ID: 12974088 [TBL] [Abstract][Full Text] [Related]
27. [Analysis of prognosis and associated factors in multiple recurrent epithelial ovarian cancer with three times or more cytoreductive surgeries]. Zou RY; Yuan L; Chen M; Yao LQ Zhonghua Fu Chan Ke Za Zhi; 2023 Mar; 58(3):198-206. PubMed ID: 36935197 [No Abstract] [Full Text] [Related]
28. [Prognostic comparison of active surveillance and adjuvant chemotherapy in the treatment of patients with stage Ⅰ ovarian immature teratoma after fertility-sparing surgery]. Zhang XY; Yang J; Xiang Y; Wu M; Pan LY; Yang JX Zhonghua Fu Chan Ke Za Zhi; 2023 Nov; 58(11):838-845. PubMed ID: 37981770 [No Abstract] [Full Text] [Related]
29. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution. Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930 [TBL] [Abstract][Full Text] [Related]
30. Pelvic masses after surgery for immature ovarian teratoma: A 10-year experience of Western China. Xie S; Jia X; Li T; Xu Y; Wu W; Qiu Y; Yuan S; Peng X; Wang H Medicine (Baltimore); 2022 Aug; 101(31):e29727. PubMed ID: 35945757 [TBL] [Abstract][Full Text] [Related]
31. Growing teratoma syndrome of the ovary: a case report with FDG-PET findings. Kikawa S; Todo Y; Minobe S; Yamashiro K; Kato H; Sakuragi N J Obstet Gynaecol Res; 2011 Jul; 37(7):926-32. PubMed ID: 21450035 [TBL] [Abstract][Full Text] [Related]
32. A case of ovarian growing teratoma syndrome treated by cytoreductive surgery. Goto Y; Mizumoto A; Hirano M; Takao N; Ichinose M; Noguchi K; Kasyu I; Ishida M; Yonemura Y Int Cancer Conf J; 2017 Oct; 6(4):188-192. PubMed ID: 31149500 [TBL] [Abstract][Full Text] [Related]
33. Growing teratoma syndrome of the ovary presenting with liver metastasis: report of a case. Soufi M; Lupinacci RM; Godiris-Petit G; Vignot S; Genestie C; Menegaux F; Lefranc JP Eur J Gynaecol Oncol; 2015; 36(4):473-6. PubMed ID: 26390706 [TBL] [Abstract][Full Text] [Related]
34. [Clinical observation of partial pancreatectomy as part of primary cytoreductive surgery in advanced epithelial ovarian cancer]. Xiang LB; Tu YX; He TC; Pei X; Shen XX; Yang WT; Wu XH; Yang HJ Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):361-5. PubMed ID: 27256444 [TBL] [Abstract][Full Text] [Related]
36. [The characteristics diagnosis and treatment of hepatic metastasis of simple immature ovarian teratoma]. Fan Q; Huang H; Lian L Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):613-6. PubMed ID: 11372414 [TBL] [Abstract][Full Text] [Related]
38. Ovary-sparing surgery for teratomas in children. Özcan R; Kuruoğlu S; Dervişoğlu S; Eliçevik M; Emir H; Büyükünal C Pediatr Surg Int; 2013 Mar; 29(3):233-7. PubMed ID: 23224440 [TBL] [Abstract][Full Text] [Related]
39. Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma. Dai Y; Zhang J; Ren H; Zhou X; Chen J; Cui L; Lang J; Guan H; Sun D Am J Obstet Gynecol; 2019 Nov; 221(5):485.e1-485.e10. PubMed ID: 31128109 [TBL] [Abstract][Full Text] [Related]
40. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome. Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ Am J Obstet Gynecol; 2019 Oct; 221(4):326.e1-326.e7. PubMed ID: 31082382 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]